New York | Pharmaceutical major Gilead Sciences has announced that the company is providing its voluntary licensing partners with technical assistance, support for the addition of new local manufacturing facilities and the donation of active pharmaceutical ingredient (API) to rapidly scale up production of Remdesivir in India that is going through a massive Covid surge. Remdesivir […]